Rafael Holdings, Inc. RFL Cost Of Product Revenue — Cost Of Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rafael Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rafael Holdings, Inc.'s cost of product revenue — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rafael Holdings, Inc.'s cost of product revenue — cost of revenue?
- Rafael Holdings, Inc. (RFL) reported cost of product revenue — cost of revenue of $8K in Q1 2026.
- What does cost of product revenue — cost of revenue mean?
- This metric represents the direct costs attributable to the production and delivery of pharmaceutical products sold by the company. It encompasses expenses such as raw materials, manufacturing overhead, and direct labor required to bring oncology therapies to market. Monitoring this figure helps investors assess the direct profitability and production efficiency of the company's clinical-stage product portfolio.